For the quarter ending 2025-09-30, COEP has $14,181,641 in assets. $3,264,864 in debts.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 4,908,487 | 1,996,726 | ||
| Accounts receivable | 82,500 | 30,000 | ||
| Marketable securities | 421,698 | 990,566 | ||
| Interest receivable | 3,541 | - | ||
| Prepaid assets | 574,636 | 677,643 | ||
| Total current assets | 5,990,862 | 3,694,935 | ||
| Furniture and fixtures | 25,237 | 25,237 | ||
| Lessaccumulated depreciation | 15,217 | 15,070 | ||
| Furniture and fixtures, net | 10,020 | 10,167 | ||
| Investments | 6,941,082 | 6,941,083 | ||
| Intangible assets, net | 406,406 | 451,563 | ||
| Co-development rights, net | 804,167 | 1,054,167 | ||
| Right of use asset, net of accumulated amortization | 29,104 | 39,564 | ||
| Total other assets | 8,180,759 | 8,486,377 | ||
| Total assets | 14,181,641 | 12,191,479 | ||
| Accounts payable | 783,103 | 1,028,826 | ||
| Accrued expenses | 210,892 | 416,209 | ||
| Convertible notes payable, net of debt discount of 0 and 435,635 | 0 | 1,042,007 | ||
| Notes payable, current portion, in default | 100,000 | 100,000 | ||
| Right of use liability, current portion | 29,865 | 21,738 | ||
| Customer deposit | 1,461,504 | 1,631,445 | ||
| Derivative liability | 0 | 0 | ||
| Other current liabilities | 120,000 | 235,000 | ||
| Total current liabilities | 2,705,364 | 4,475,225 | ||
| Sba loan payable | 150,000 | 150,000 | ||
| Derivative liability warrants | 409,500 | 467,250 | ||
| Right of use liability, non-current portion | 0 | 18,874 | ||
| Total long term liabilities | 559,500 | 636,124 | ||
| Preferred stock, 0.0001 par value, 10,000,000 shares authorized, 625 and 6,250 shares issued and outstanding at june 30, 2025 and december 31, 2024, respectively | - | 1 | ||
| Total liabilities | 3,264,864 | 5,111,349 | ||
| Common stock, 0.0001 par value, 150,000,000 shares authorized, 5,157,611 and 2,116,191 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 516 | 416 | ||
| Additional paid-in capital | 120,841,292 | 111,850,568 | ||
| Subscription receivable | 2,100,368 | 125,000 | ||
| Common stock subscribed | - | 359,046 | ||
| Accumulated deficit | -108,375,858 | -105,989,201 | ||
| Total stockholders' equity - controlling interests | 10,365,582 | 6,095,830 | ||
| Total stockholders' equity - noncontrolling interests | 551,195 | 984,300 | ||
| Total stockholders' equity | 10,916,777 | 7,080,130 | ||
| Total liabilities and stockholders' equity | 14,181,641 | 12,191,479 | ||
Coeptis Therapeutics Holdings, Inc. (COEP)
Coeptis Therapeutics Holdings, Inc. (COEP)